TITLE

Insulin Sensitivity, Insulinemia, and Coronary Artery Disease

AUTHOR(S)
Rewers, Marian; Zaccaro, Daniel; D'agostino Jr., Ralph; Haffner, Steven; Saad, Mohammed F.; Selby, Joe V.; Bergman, Richard; Savage, Peter
PUB. DATE
March 2004
SOURCE
Diabetes Care;Mar2004, Vol. 27 Issue 3, p781
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The aim of this study was to evaluate whether low insulin sensitivity (S1) measured using a modified frequently sampled intravenous glucose tolerance test with minimal model analysis is associated with coronary artery disease (CAD) independent of other cardiovascular risk factors. The odds ratio (OR) for CAD was greatest among individuals in the two lowest quintiles of S1 (2.4, 95% CI 1.0–5.6 and 4.7, 2.1–10.7) compared with the highest S1 quintile. After adjusting for demographic and cardiovascular risk factors, a decrement from the 75th to 25th percentile in S1, was associated with a 56% increase in CAD (P = 0.028). Similar increments in fasting or 2-h insulin levels were associated with, respectively, only 15 (NS) and 3% (NS) increases in CAD. The association between S1, and CAD was partially mediated by insulin, HDL cholesterol and triglyceride levels, hypertension, diabetes, and obesity, but not LDL cholesterol or cigarette smoking. Low S1 is associated with CAD independently of and stronger than plasma insulin levels. Part of the association is accounted for by dyslipidemia, hypertension, diabetes, and obesity.
ACCESSION #
12421013

 

Related Articles

  • Impact of Obesity on Work Productivity among Individuals with Type 2 Diabetes Mellitus and Varied Levels of Cardiometabolic Risk. Stewart, Walter F.; Chapman, Richard H.; Gavin III, James R.; Fox, Kathleen M.; Grandy, Susan // Diabetes;Jun2007 Supplement 1, Vol. 56, pA249 

    Little is known about the work impact of obesity and of diabetes. We evaluated work absence and work effectiveness among nine subgroups of individuals defined by BMI (i.e., 30+ or obese, 25-25.99 or overweight, and <25 or normal weight) and diabetes (i.e., self-reported type 2 diabetes [T2D],...

  • Biological effects of bariatric surgery on obesity-related comorbidities. Noria, Sabrena F.; Grantcharov, Teodor // Canadian Journal of Surgery;Feb2013, Vol. 56 Issue 1, p47 

    The article presents information regarding the effect of bariatric surgery over the disorders accompanied by obesity. It mentions several disorders of obesity which includes blood pressure, Type 2 diabetes and blood cholesterol level which in turn cause coronary heart disease. It states that...

  • Insulin Resistance, Hyperinsulinemia, and Hypertriglyceridemia in Patients with Coronary Artery Disease Independent of Obesity. Psyrogiannis, Agathoklis J.; Alexopoulos, Dimitris K.; Kyriazopoulou, Venetsana E.; Vagenakis, Apostolos G. // Angiology;Aug1998, Vol. 49 Issue 8, p607 

    Insulin resistance and hyperinsulinemia both in normal persons and those with non-insulin dependent diabetes mellitus (NIDDM) (type 2 diabetes) appears to be related to obesity. It seems also that insulin plays a role in modulating the obesity-related factors (eg, hyperinsulinemia,...

  • Assessing The Impact of Physical Exercise on The Health and Well-being of Older Persons In Nigeria. Wahab, Elias; Oladipupo-Okorie, O. B.; Sadiku, A. O.; David, Oyebade; Akinde; Bosun, Jubril // Indian Journal of Gerontology;2012, Vol. 26 Issue 3, p339 

    The article examines the impact of exercise on the health and well-being of the elderly in Nigeria. It cites the common illnesses of the aged which can be controlled and prevented through exercise, including coronary heart disease (CHD), stroke, Type II diabetes, obesity and hypertension. It...

  • INSIGHTS INTO OBESITY'S PATHOGENESIS AND PHARMACOLOGICAL MANAGEMENT. Galoiu, S. // Acta Endocrinologica (1841-0987);2015, Vol. 11 Issue 2, p262 

    Obesity is an increasing public health problem, the fifth leading risk for global deaths according to WHO. It is associated with major comorbidities, such as type 2 diabetes mellitus, ischemic heart disease, hypertension, dyslipidemia, sleep apnea, osteoarthritis, nonalcoholic fatty liver...

  • Simvastatin reduced mortality and vascular events in diabetes mellitus.  // ACP Journal Club;Jan/Feb2004, Vol. 140 Issue 1, p1 

    This article focuses on a study related to patients with diabetes mellitus, published in the 2003 issue of the journal "Lancet." It is a heart protection study of cholesterol-lowering with simvastatin drug in 5963 people with diabetes. The patients had a medical history of diabetes mellitus,...

  • Chronic Complications of Diabetes in Iraq: Experience from Southern Iraq. Ali Mansour, Abbas // Clinical Medicine Insights: Endocrinology & Diabetes;2010, Issue 3, p89 

    Background: The aim of this study is to evaluate the prevalence of chronic complications in type 2 diabetic patients in Basrah (Southern Iraq). Methods: This was a longitudinal descriptive study for patients with diabetes registered in Al-Faiha Diabetes and Endocrine Centre in Basrah (Southern...

  • Metabolic syndrome.  // BMJ: British Medical Journal (International Edition);11/19/2005, Vol. 331 Issue 7526, p1153 

    This article reports on how metabolic syndrome raises cardiovascular risk. Insulin resistance appears to be the main force leading to the increased risk of mortality from coronary heart disease among people with metabolic syndrome, which is characterized by hyperinsulinaemia, low glucose...

  • Reducing risk factors could eradicate CHD.  // Pulse;1/13/2003, Vol. 63 Issue 2, p16 

    Focuses on the advantages of reducing population levels of high total cholesterol, high blood pressure and smoking in preventing the development of coronary heart disease.

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics